Development of a cross platform IR-MALDESI front end for high throughput mass spectrometry

AstraZeneca and TTP collaborated to develop and test an IR-MALDESI prototype that can seamlessly interface with mass spectrometers from different vendors. The instrument enables a throughput in excess of 10 samples per second.
At TTP, we bring together world-leading scientists and engineers to deliver cutting-edge diagnostics product development solutions today. To learn more about our work, visit: www.ttp.com/in...